0CF Stock Chart & Stats
€0.13
€0.00(0.00%)
At close: 4:00 PM EST
€0.13
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.19
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€9.08M
Enterprise Value€216.62
Total Cash (Recent Filing)€3.05M
Total Debt (Recent Filing)€77.43M
Price to Earnings (P/E)―
Beta2.12
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding183,219,120
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.01
Revenue Forecast (FY)€10.38M
Bulls Say, Bears Say
Bulls Say
Sustainable Bio-based ChemistryOrganoClick’s core business of bio-based chemical technologies targets sustainable material treatment across wood, textiles and industrial surfaces. This aligns with structural regulatory and corporate ESG trends, supporting durable demand and differentiation versus fossil-based incumbents.
Improving Operating Cash GenerationOperating cash flow turning positive demonstrates improving underlying cash generation versus the prior year, reducing short-term liquidity strain. If sustained, this narrows reliance on external financing, enables modest reinvestment and supports scaling production or customer onboarding over the medium term.
Proprietary Product And Commercialization ModelA product-based commercial model built on proprietary chemistry creates potential recurring revenue from supply contracts and treated materials. Proprietary IP and integrated offerings raise switching costs, enable margin recovery opportunities, and open future licensing or collaboration revenue streams if industrial adoption expands.
Bears Say
Declining Revenue And Weak MarginsA multi-year pattern of revenue decline and deeply negative net margins reflects persistent demand or pricing pressure and weak gross profitability (~14–15%). Continued top-line contraction and low margins impede the company’s ability to build reserves or fund growth internally, prolonging recovery timelines.
Very High LeverageDebt of 77.4m versus thin equity (14.0m) yields extreme leverage, raising refinancing and solvency risk especially given ongoing losses. High leverage limits strategic flexibility, increases interest burdens, and heightens vulnerability to revenue or margin shocks over the medium term.
Persistent Negative Free Cash FlowDespite OCF improvement, persistent negative free cash flow means the business still consumes cash after investments. This constrains organic reinvestment, forces reliance on external capital or debt, and raises dilution or funding risk if operational improvements do not convert into sustained positive FCF.
OrganoClick AB News
0CF FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was <€0.01 and its highest was €0.19 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is €9.08M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is Aug 12, 2026 which is in 19 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on May 06, 2026. The company reported -€0.001 earnings per share for the quarter, beating the consensus estimate of -€0.002 by <€0.001.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 183,219,120 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -€0.001 in its last earnings report, beating expectations of -€0.002. Following the earnings report the stock price went down -20%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in DE:0CF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.
Technical Analysis
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Impact Coatings AB
―
XP Chemistries AB
―